Welcome to our dedicated page for NiSource news (Ticker: $NI), a resource for investors and traders seeking the latest updates and insights on NiSource stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect NiSource's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of NiSource's position in the market.
NiSource Inc. announced their first-quarter 2024 results, reporting a net income of $344.3 million and adjusted EPS of $0.85, compared to $319.2 million and $0.77 in the same period of 2023. NiSource reaffirmed their 2024 adjusted EPS guidance of $1.70-1.74 and a 6-8% annual EPS growth for 2023-2028. The base capital expenditure plan for 2024-2028 is increased to $16.4 billion. The company's President and CEO, Lloyd Yates, highlighted the positive impact of employee efforts and continued investment in service reliability for customers.